Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats

2023-06-222023-06-22https://digital.cic.gba.gob.ar/handle/11746/11952Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in ratsArtículo